Antiverse Ltd.

https://www.antiverse.io

LinkedIn: https://www.linkedin.com/company/antiverse

Antiverse is an artificial intelligence-driven techbio company that specialises in antibody design against difficult-to-drug targets, including G-protein coupled receptors (GPCRs) and ion channels. Headquartered in Cardiff, UK and with offices in Boston, MA, Antiverse combines state-of-the-art machine learning techniques and advanced cell line engineering to develop de novo antibody therapeutics. With a main focus on establishing long-term partnerships, Antiverse has collaborated with two top 20 global pharmaceutical companies. In addition, they are developing a strong internal pipeline of antibodies against several challenging drug targets across various indications. *

	Start	2017-01-01 established
	Industry	AI-based drug discovery / AI-based drug development
	Industry 2	therapeutic antibody
	Person	Tunaboylu, Murat (Antiverse 202103 CEO + Co-Founder)

	Region	Cardiff
	Country	United Kingdom (GB)
	City	CF14 4UJ Cardiff
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Antiverse Ltd.. (10/16/23). "Press Release: Antiverse and GlobalBio, Inc. Extend Collaboration to Advance Antibody Cancer Therapeutics". Cardiff & Cambridge, MA.

		Record changed: 2024-11-06